Clinical Trials Directory

Trials / Unknown

UnknownNCT04670952

Potential Pulmonary Benefit of Low Pressure Laparoscopic Cholecystectomy in Selected Patients

The Pulmonary Effects of Low Pressure Versus Standard Pressure Laparoscopic Cholecystectomy in Patients With Cardiopulmonary Disorders: A Prospective Randomized Controlled Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
140 (estimated)
Sponsor
Peking Union Medical College Hospital · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

Standard Pressure Laparoscopic Cholecystectomy,as the standard for cholecystectomy, can lead to about 15% of pulmonary atelectasis. According to literature, low pressure laparoscopic cholecystectomy is thought to probably decrease cardio-pulmonary related complications and postoperative pain. However, the previous studies have presented controversial results. Our study aim to evaluate the potential pulmonary benefit of low pressure laparoscopic cholecystectomy in elderly or patients accompanied with cardio-pulmonary disorders.

Detailed description

Standard Pressure Laparoscopic Cholecystectomy, SPLC;12-16mmHg,as the standard for cholecystectomy, can lead to about 15% of pulmonary atelectasis. According to literature, Low Pressure Laparoscopic Cholecystectomy, LPLC;8-10mmHg is thought to probably decrease cardio-pulmonary related complications and postoperative pain. However, most of the existing study have combined population with all age scale, bringing bias to the result. Our study aim to evaluate the potential pulmonary benefit of low pressure laparoscopic cholecystectomy in elderly or patients accompanied with cardio-pulmonary disorders.

Conditions

Interventions

TypeNameDescription
OTHERLow Pressure Laparoscopic CholecystectomyLow Pressure Laparoscopic Cholecystectomy (10mmHg) is set as the experimental group.
OTHERStandard Pressure Laparoscopic CholecystectomyStandard Pressure Laparoscopic Cholecystectomy (14mmHg) is set as the control group.

Timeline

Start date
2019-06-10
Primary completion
2021-11-01
Completion
2021-12-01
First posted
2020-12-17
Last updated
2020-12-23

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04670952. Inclusion in this directory is not an endorsement.